Clinical Characteristics of Stenotrophomonas maltophilia Keratitis. Issue 6 (June 2016)

• Record Type: Journal Article
• Authors: Wu, An-Lun; Yeh, Lung-Kun; Ma, David H. K.; Chen, Phil Y. F.; Lin, Hsin-Chiung; Sun, Chi-Chin; Tan, Hsin-Yuan; Chen, Hung-Chi; Chen, Shin-Yi; Hsiao, Ching-Hsi
• Is Part Of: Cornea. Volume 35:Issue 6(2016)
• Publication Date: 2016-06
• Subjects: Stenotrophomonas maltophilia -- keratitis -- corneal ulcer -- drug susceptibility; Cornea -- Periodicals; Cornea -- Periodicals; Cornée -- Périodiques; 617.719
• DOI: 10.1097/ICO.0000000000000855
• Languages: English
• ISSNs: 0277-3740

Abstract

Abstract : Purpose: Stenotrophomonas maltophilia is an important opportunistic pathogen but an uncommon cause of corneal infections. This study aimed to report the clinical features, antibiotic susceptibility, treatments, and visual outcomes of S. maltophilia keratitis. Methods: The medical records of 21 patients with culture-proven S. maltophilia –associated infectious keratitis in our hospital between January 1, 2003, and December 31, 2014, were retrospectively reviewed. The clinical features of patients with S. maltophilia keratitis were compared with those of patients from 17 previously reported cases. Results: The most common risk factors for S. maltophilia keratitis were preexisting corneal disease or previous corneal surgery (16), followed by soft contact lens wear (9). Nine patients (42.9%) were multifactorial. Polymicrobial infections was detected in 12 eyes (57.1%). All S. maltophilia isolates were susceptible to levofloxacin and moxifloxacin. A total of 17 of 21 patients (81.0%) had favorable responses to topical antimicrobial treatment, and 10 (47.6%) required surgical intervention for promotion of reepithelialization (6) and corneal perforation (4). Final vision ranged from light perception to 20/20. The clinical features of S. maltophilia keratitis in our cases and in previously reported cases were similar. Conclusions: S. maltophilia keratitis primarily affects patients with compromised ocular surfaces. S. maltophilia demonstrates in vitro susceptibility and a strong clinical response to fluoroquinolones.